Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | A2274T |
Impact List | missense |
Protein Effect | no effect - predicted |
Gene Variant Descriptions | ATM A2274T lies within the FAT domain of the Atm protein (UniProt.org). A2274T results in phosphorylation levels of Atm and downstream targets similar to wild-type Atm in response to irradiation in cultured cells (PMID: 19431188), and leads to kinase activity, radiosensitivity, and radiation-induced chromosome aberrations similar to wild-type protein in cultured cells (PMID: 11805335), and therefore, is predicted to have no effect on Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM A2274T |
Transcript | NM_000051.4 |
gDNA | chr11:g.108326070G>A |
cDNA | c.6820G>A |
Protein | p.A2274T |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005271561 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542844.4 | chr11:g.108332837G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542844 | chr11:g.108332837G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542844.3 | chr11:g.108332837G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542843 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108326070G>A | c.6820G>A | p.A2274T | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|